Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
RNA interference (RNAi) is a biological process in which RNA molecules inhibit gene expression, typically by causing the destruction of specific mRNA molecules. Historically, it was known by other names, including co-suppression, post-transcriptional gene silencing (PTGS), and quelling. Only after these apparently unrelated processes were fully understood did it become clear that they all described the RNAi phenomenon. RNAi is now known as precise, efficient, stable and better than antisense technology for gene suppression.
This report offers an overview of the market trends, drivers, and barriers with respect to the USA RNAi for Therapeutic Consumption market. It also provides a detailed overview of the market of different regions across West USA, South USA, Middle West USA, Northeast USA. The report deeply analyzes type and application in the USA RNAi for Therapeutic Consumption market. Detailed analysis of key players, along with key growth strategies adopted by RNAi for Therapeutic Consumption industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
miRagen Therapeutics
Dicerna Pharmaceuticals
Quark Pharmaceuticals
RXi Pharmaceuticals
Sirnaomics
Alnylam Pharmaceuticals
Mirna Therapeutics
Gradalis
Arrowhead
By Type:
siRNA
miRNA
shRNA
By End-User:
Cancer
Cardiovascular
HBV
Other
By Region:
-
West USA
-
South USA
-
Middle West USA
-
Northeast USA
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of RNAi for Therapeutic Consumption Market
-
1.3 Market Segment by Type
-
1.3.1 USA RNAi for Therapeutic Consumption Market Size and Growth Rate of siRNA from 2016 to 2027
-
1.3.2 USA RNAi for Therapeutic Consumption Market Size and Growth Rate of miRNA from 2016 to 2027
-
1.3.3 USA RNAi for Therapeutic Consumption Market Size and Growth Rate of shRNA from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 USA RNAi for Therapeutic Consumption Market Size and Growth Rate of Cancer from 2016 to 2027
-
1.4.2 USA RNAi for Therapeutic Consumption Market Size and Growth Rate of Cardiovascular from 2016 to 2027
-
1.4.3 USA RNAi for Therapeutic Consumption Market Size and Growth Rate of HBV from 2016 to 2027
-
1.4.4 USA RNAi for Therapeutic Consumption Market Size and Growth Rate of Other from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 West USA RNAi for Therapeutic Consumption Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 South USA RNAi for Therapeutic Consumption Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 Middle West USA RNAi for Therapeutic Consumption Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 Northeast USA RNAi for Therapeutic Consumption Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of RNAi for Therapeutic Consumption Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of RNAi for Therapeutic Consumption by Major Types
-
3.4.1 Market Size and Growth Rate of siRNA
-
3.4.2 Market Size and Growth Rate of miRNA
-
3.4.3 Market Size and Growth Rate of shRNA
4 Segmentation of RNAi for Therapeutic Consumption Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of RNAi for Therapeutic Consumption by Major End-Users
-
4.4.1 Market Size and Growth Rate of RNAi for Therapeutic Consumption in Cancer
-
4.4.2 Market Size and Growth Rate of RNAi for Therapeutic Consumption in Cardiovascular
-
4.4.3 Market Size and Growth Rate of RNAi for Therapeutic Consumption in HBV
-
4.4.4 Market Size and Growth Rate of RNAi for Therapeutic Consumption in Other
5 Market Analysis by Regions
-
5.1 USA RNAi for Therapeutic Consumption Production Analysis by Regions
-
5.2 USA RNAi for Therapeutic Consumption Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on USA Economy
6 West USA RNAi for Therapeutic Consumption Landscape Analysis
-
6.1 West USA RNAi for Therapeutic Consumption Landscape Analysis by Major Types
-
6.2 West USA RNAi for Therapeutic Consumption Landscape Analysis by Major End-Users
7 South USA RNAi for Therapeutic Consumption Landscape Analysis
-
7.1 South USA RNAi for Therapeutic Consumption Landscape Analysis by Major Types
-
7.2 South USA RNAi for Therapeutic Consumption Landscape Analysis by Major End-Users
8 Middle West USA RNAi for Therapeutic Consumption Landscape Analysis
-
8.1 Middle West USA RNAi for Therapeutic Consumption Landscape Analysis by Major Types
-
8.2 Middle West USA RNAi for Therapeutic Consumption Landscape Analysis by Major End-Users
9 Northeast USA RNAi for Therapeutic Consumption Landscape Analysis
-
9.1 Northeast USA RNAi for Therapeutic Consumption Landscape Analysis by Major Types
-
9.2 Northeast USA RNAi for Therapeutic Consumption Landscape Analysis by Major End-Users
10 Major Players Profiles
-
10.1 miRagen Therapeutics
-
10.1.1 miRagen Therapeutics Company Profile and Recent Development
-
10.1.2 Market Performance
-
10.1.3 Product and Service Introduction
-
10.2 Dicerna Pharmaceuticals
-
10.2.1 Dicerna Pharmaceuticals Company Profile and Recent Development
-
10.2.2 Market Performance
-
10.2.3 Product and Service Introduction
-
10.3 Quark Pharmaceuticals
-
10.3.1 Quark Pharmaceuticals Company Profile and Recent Development
-
10.3.2 Market Performance
-
10.3.3 Product and Service Introduction
-
10.4 RXi Pharmaceuticals
-
10.4.1 RXi Pharmaceuticals Company Profile and Recent Development
-
10.4.2 Market Performance
-
10.4.3 Product and Service Introduction
-
10.5 Sirnaomics
-
10.5.1 Sirnaomics Company Profile and Recent Development
-
10.5.2 Market Performance
-
10.5.3 Product and Service Introduction
-
10.6 Alnylam Pharmaceuticals
-
10.6.1 Alnylam Pharmaceuticals Company Profile and Recent Development
-
10.6.2 Market Performance
-
10.6.3 Product and Service Introduction
-
10.7 Mirna Therapeutics
-
10.7.1 Mirna Therapeutics Company Profile and Recent Development
-
10.7.2 Market Performance
-
10.7.3 Product and Service Introduction
-
10.8 Gradalis
-
10.8.1 Gradalis Company Profile and Recent Development
-
10.8.2 Market Performance
-
10.8.3 Product and Service Introduction
-
10.9 Arrowhead
-
10.9.1 Arrowhead Company Profile and Recent Development
-
10.9.2 Market Performance
-
10.9.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure USA RNAi for Therapeutic Consumption Market Size and Growth Rate of siRNA from 2016 to 2027
-
Figure USA RNAi for Therapeutic Consumption Market Size and Growth Rate of miRNA from 2016 to 2027
-
Figure USA RNAi for Therapeutic Consumption Market Size and Growth Rate of shRNA from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2020
-
Figure Market Share by Type in 2027
-
Figure USA RNAi for Therapeutic Consumption Market Size and Growth Rate of Cancer from 2016 to 2027
-
Figure USA RNAi for Therapeutic Consumption Market Size and Growth Rate of Cardiovascular from 2016 to 2027
-
Figure USA RNAi for Therapeutic Consumption Market Size and Growth Rate of HBV from 2016 to 2027
-
Figure USA RNAi for Therapeutic Consumption Market Size and Growth Rate of Other from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2020
-
Figure Market Share by End-User in 2027
-
Figure West USA RNAi for Therapeutic Consumption Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South USA RNAi for Therapeutic Consumption Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Middle West USA RNAi for Therapeutic Consumption Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast USA RNAi for Therapeutic Consumption Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of RNAi for Therapeutic Consumption Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2019
-
Figure Market Share of TOP 5 Players in 2019
-
Figure Market Share of TOP 6 Players from 2016 to 2020
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Distribution Map of USA
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of RNAi for Therapeutic Consumption
-
Figure Development Trends of Different Types
-
Table Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of RNAi for Therapeutic Consumption by Different Types from 2016 to 2027
-
Table Consumption Share of RNAi for Therapeutic Consumption by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of siRNA
-
Figure Market Size and Growth Rate of miRNA
-
Figure Market Size and Growth Rate of shRNA
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of RNAi for Therapeutic Consumption by Different End-Users from 2016 to 2027
-
Table Consumption Share of RNAi for Therapeutic Consumption by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of Cancer
-
Figure Market Size and Growth Rate of Cardiovascular
-
Figure Market Size and Growth Rate of HBV
-
Figure Market Size and Growth Rate of Other
-
Table USA RNAi for Therapeutic Consumption Production by Regions
-
Table USA RNAi for Therapeutic Consumption Production Share by Regions
-
Figure USA RNAi for Therapeutic Consumption Production Share by Regions in 2016
-
Figure USA RNAi for Therapeutic Consumption Production Share by Regions in 2021
-
Figure USA RNAi for Therapeutic Consumption Production Share by Regions in 2027
-
Table USA RNAi for Therapeutic Consumption Consumption by Regions
-
Table USA RNAi for Therapeutic Consumption Consumption Share by Regions
-
Figure USA RNAi for Therapeutic Consumption Consumption Share by Regions in 2016
-
Figure USA RNAi for Therapeutic Consumption Consumption Share by Regions in 2021
-
Figure USA RNAi for Therapeutic Consumption Consumption Share by Regions in 2027
-
Table West USA RNAi for Therapeutic Consumption Consumption by Types from 2016 to 2027
-
Table West USA RNAi for Therapeutic Consumption Consumption Share by Types from 2016 to 2027
-
Figure West USA RNAi for Therapeutic Consumption Consumption Share by Types in 2016
-
Figure West USA RNAi for Therapeutic Consumption Consumption Share by Types in 2021
-
Figure West USA RNAi for Therapeutic Consumption Consumption Share by Types in 2027
-
Table West USA RNAi for Therapeutic Consumption Consumption by End-Users from 2016 to 2027
-
Table West USA RNAi for Therapeutic Consumption Consumption Share by End-Users from 2016 to 2027
-
Figure West USA RNAi for Therapeutic Consumption Consumption Share by End-Users in 2016
-
Figure West USA RNAi for Therapeutic Consumption Consumption Share by End-Users in 2021
-
Figure West USA RNAi for Therapeutic Consumption Consumption Share by End-Users in 2027
-
Table South USA RNAi for Therapeutic Consumption Consumption by Types from 2016 to 2027
-
Table South USA RNAi for Therapeutic Consumption Consumption Share by Types from 2016 to 2027
-
Figure South USA RNAi for Therapeutic Consumption Consumption Share by Types in 2016
-
Figure South USA RNAi for Therapeutic Consumption Consumption Share by Types in 2021
-
Figure South USA RNAi for Therapeutic Consumption Consumption Share by Types in 2027
-
Table South USA RNAi for Therapeutic Consumption Consumption by End-Users from 2016 to 2027
-
Table South USA RNAi for Therapeutic Consumption Consumption Share by End-Users from 2016 to 2027
-
Figure South USA RNAi for Therapeutic Consumption Consumption Share by End-Users in 2016
-
Figure South USA RNAi for Therapeutic Consumption Consumption Share by End-Users in 2021
-
Figure South USA RNAi for Therapeutic Consumption Consumption Share by End-Users in 2027
-
Table Middle West USA RNAi for Therapeutic Consumption Consumption by Types from 2016 to 2027
-
Table Middle West USA RNAi for Therapeutic Consumption Consumption Share by Types from 2016 to 2027
-
Figure Middle West USA RNAi for Therapeutic Consumption Consumption Share by Types in 2016
-
Figure Middle West USA RNAi for Therapeutic Consumption Consumption Share by Types in 2021
-
Figure Middle West USA RNAi for Therapeutic Consumption Consumption Share by Types in 2027
-
Table Middle West USA RNAi for Therapeutic Consumption Consumption by End-Users from 2016 to 2027
-
Table Middle West USA RNAi for Therapeutic Consumption Consumption Share by End-Users from 2016 to 2027
-
Figure Middle West USA RNAi for Therapeutic Consumption Consumption Share by End-Users in 2016
-
Figure Middle West USA RNAi for Therapeutic Consumption Consumption Share by End-Users in 2021
-
Figure Middle West USA RNAi for Therapeutic Consumption Consumption Share by End-Users in 2027
-
Table Northeast USA RNAi for Therapeutic Consumption Consumption by Types from 2016 to 2027
-
Table Northeast USA RNAi for Therapeutic Consumption Consumption Share by Types from 2016 to 2027
-
Figure Northeast USA RNAi for Therapeutic Consumption Consumption Share by Types in 2016
-
Figure Northeast USA RNAi for Therapeutic Consumption Consumption Share by Types in 2021
-
Figure Northeast USA RNAi for Therapeutic Consumption Consumption Share by Types in 2027
-
Table Northeast USA RNAi for Therapeutic Consumption Consumption by End-Users from 2016 to 2027
-
Table Northeast USA RNAi for Therapeutic Consumption Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast USA RNAi for Therapeutic Consumption Consumption Share by End-Users in 2016
-
Figure Northeast USA RNAi for Therapeutic Consumption Consumption Share by End-Users in 2021
-
Figure Northeast USA RNAi for Therapeutic Consumption Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of miRagen Therapeutics
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of miRagen Therapeutics
-
Figure Sales and Growth Rate Analysis of miRagen Therapeutics
-
Figure Revenue and Market Share Analysis of miRagen Therapeutics
-
Table Product and Service Introduction of miRagen Therapeutics
-
Table Company Profile and Development Status of Dicerna Pharmaceuticals
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Dicerna Pharmaceuticals
-
Figure Sales and Growth Rate Analysis of Dicerna Pharmaceuticals
-
Figure Revenue and Market Share Analysis of Dicerna Pharmaceuticals
-
Table Product and Service Introduction of Dicerna Pharmaceuticals
-
Table Company Profile and Development Status of Quark Pharmaceuticals
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Quark Pharmaceuticals
-
Figure Sales and Growth Rate Analysis of Quark Pharmaceuticals
-
Figure Revenue and Market Share Analysis of Quark Pharmaceuticals
-
Table Product and Service Introduction of Quark Pharmaceuticals
-
Table Company Profile and Development Status of RXi Pharmaceuticals
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of RXi Pharmaceuticals
-
Figure Sales and Growth Rate Analysis of RXi Pharmaceuticals
-
Figure Revenue and Market Share Analysis of RXi Pharmaceuticals
-
Table Product and Service Introduction of RXi Pharmaceuticals
-
Table Company Profile and Development Status of Sirnaomics
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sirnaomics
-
Figure Sales and Growth Rate Analysis of Sirnaomics
-
Figure Revenue and Market Share Analysis of Sirnaomics
-
Table Product and Service Introduction of Sirnaomics
-
Table Company Profile and Development Status of Alnylam Pharmaceuticals
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Alnylam Pharmaceuticals
-
Figure Sales and Growth Rate Analysis of Alnylam Pharmaceuticals
-
Figure Revenue and Market Share Analysis of Alnylam Pharmaceuticals
-
Table Product and Service Introduction of Alnylam Pharmaceuticals
-
Table Company Profile and Development Status of Mirna Therapeutics
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Mirna Therapeutics
-
Figure Sales and Growth Rate Analysis of Mirna Therapeutics
-
Figure Revenue and Market Share Analysis of Mirna Therapeutics
-
Table Product and Service Introduction of Mirna Therapeutics
-
Table Company Profile and Development Status of Gradalis
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Gradalis
-
Figure Sales and Growth Rate Analysis of Gradalis
-
Figure Revenue and Market Share Analysis of Gradalis
-
Table Product and Service Introduction of Gradalis
-
Table Company Profile and Development Status of Arrowhead
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Arrowhead
-
Figure Sales and Growth Rate Analysis of Arrowhead
-
Figure Revenue and Market Share Analysis of Arrowhead
-
Table Product and Service Introduction of Arrowhead
-
